In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 62 for your search:
Cancer Type/Condition:  Rectal cancer
Trial Type:  Screening
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Screening
Status: Active
Age: 58 to 60
Sponsor: Other
Protocol IDs: 14334-c27.2, NCT01739608

2.

Phase: Phase IV
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: PEGOP0613, NCT01887158

3.

Phase: Phase IV
Type: Diagnostic, Screening
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: 6011440, DMED-1658-13, NCT02065037

4.

Phase: Phase III, Phase II
Type: Screening
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 190-CLD-AOS, NCT00867724

5.

Phase: Phase III
Type: Screening
Status: Active
Age: 55 to 64
Sponsor: Other
Protocol IDs: NordICC, NCT00883792

6.

Phase: Phase III
Type: Natural history/Epidemiology, Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000654114, FFCD-PRODIGE-13, 2009-A00536-51, EU-20979, PRODIGE 13, FFCD 0902, NCT00995202

7.

Phase: Phase III
Type: Diagnostic, Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CRE-2011.125-T, NCT01434199

8.

Phase: Phase III
Type: Screening
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 5130003, LLUMCGI2013, NCT01782014

9.

Phase: Phase II, Phase I
Type: Diagnostic, Screening, Treatment
Status: Approved-not yet active
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSP-IL-LIT-0703_S_01, NCT00715325

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Screening
Status: Active
Age: 50 to 80
Sponsor: NCI
Protocol IDs: NCCTG-GLNE010, GLNE 010, GLNE010, NCT01511653

11.

Phase: Phase II
Type: Screening
Status: Active
Age: 50 to 74
Sponsor: NCI, Other
Protocol IDs: UH3CA188640, 1UH2AT007782-01, NCT01742065

12.

Phase: Phase II
Type: Screening
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: WCTU065, NCT01972451

13.

Phase: Phase I
Type: Screening
Status: Active
Age: 45 to 80
Sponsor: Other
Protocol IDs: 633, NCT00124163

14.

Phase: Phase I
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 9461701245, NCT00302679

15.

Phase: No phase specified
Type: Screening
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: 9461700610, NCT00173277

16.

Phase: No phase specified
Type: Educational/Counseling/Training, Screening
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: 070504, NCT00534053

17.

Phase: No phase specified
Type: Natural history/Epidemiology, Screening, Tissue collection/Repository
Status: Active
Age: 40 to 75
Sponsor: NCI, Other
Protocol IDs: CDR0000583154, VU-VICC-GI-0294, VU-VICC-020603, VU-VICC-020531, VICC-GI-0294, NCT00625066

18.

Phase: No phase specified
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AR0002, 00371, NCT00613262

19.

Phase: No phase specified
Type: Screening, Supportive care
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 200802031R, NCT00745927

20.

Phase: No phase specified
Type: Screening
Status: Active
Age: 30 and over
Sponsor: Other
Protocol IDs: HIC0809004192, NCT00859625

21.

Phase: No phase specified
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ASC-FIT, NCT00892593

22.

Phase: No phase specified
Type: Screening
Status: Active
Age: 35 to 49
Sponsor: Other
Protocol IDs: UHN REB 07-0708-CE, NCT00982059

23.

Phase: No phase specified
Type: Diagnostic, Screening
Status: Active
Age: 19 to 65
Sponsor: Other
Protocol IDs: H08-00776, NCT01181739

24.

Phase: No phase specified
Type: Screening
Status: Active
Age: 21 to 85
Sponsor: Other
Protocol IDs: AR0006, NCT01211132

25.

Phase: No phase specified
Type: Screening
Status: Approved-not yet active
Age: 18 to 85
Sponsor: Pharmaceutical / Industry
Protocol IDs: AR0005, NCT01214031
1    
New Search